Annexon, Inc. (ANNX) income statement
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$3.52+0.05 (+1.44%)
Close on Nov 18, 2026Market cap $719.65MP/E –Yield 0.00%
Annexon, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -81.9%
Financial strength
- Current ratio
- 5.53
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 517.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.87
- Dividend yield
- 0.00%
See a number that looks wrong?